ASHA Learning Pass

Log in and check out the Dashboard to view featured courses.

Filter Courses By
Experience
Instructional Level
Results 31 - 40 of 202
Presenter(s): Michelle Leigh Arnold, AuD, CCC-A; Debra Dobbs, PhD
Credit(s): PDHs: 0.5, ASHA CEUs*: 0.05
Summary: Older adults must make important decisions about their end-of-life care, and those with hearing and other communication disorders need special accommodations to participate in these important decisions to the fullest extent possible. This session discusses the communication needs of patients in the final stages of life, including the use of various hearing technologies, such as hearing aids, personal sound amplifiers, and pocket talkers. The presenters discuss tools to facilitate conversations among patients, family members, and caregivers.
Presenter(s): Samira B Anderson, PhD, CCC-A
Credit(s): PDHs: 1.0, ASHA CEUs*: 0.1
Summary: The field of audiology focuses mostly on the peripheral auditory system-in both diagnosis and management-but other factors (e.g., "hidden hearing loss" and/or reduced cognitive ability) may play a role in an individual's ability to communicate in diverse environments. This session discusses how audiologists can incorporate evoked potential testing into the assessment battery to obtain a more comprehensive picture of auditory function.
Presenter(s): Victoria A Sanchez, AuD, PhD, CCC-A, F-AAA; Ann Clock Eddins, PhD, MBA, CCC-A, FAAA
Credit(s): PDHs: 0.5, ASHA CEUs*: 0.05
Summary: Emerging treatment approaches for age-related hearing loss include alternative interventions aimed at ameliorating symptoms and slowing down or even preventing hearing loss, in contrast with current treatment approaches, which focus primarily on amplification and communication strategies. This session will explore up-and-coming approaches, such as pre-clinical investigation of hormones (e.g., Aldosterone) correlated with auditory function; medicinal-related interventions; and challenges to timelines to bring new treatments to market.
Credit(s): PDHs: 3.0, ASHA CEUs*: 0.3
Summary: This SIG 9 Perspectives course includes three articles from a forum on pediatric hearing health care disparities. The articles discuss barriers to follow-up in Early Hearing Detection and Intervention (EHDI) programs; systematic evaluation of family barriers to care; and the principles and implementation of trauma-informed care in pediatric hearing health care.
Presenter(s): Elizabeth Adams Costa, PhD
Credit(s): PDHs: 1.0, ASHA CEUs*: 0.1
Summary: Published research indicates that outcomes in children with hearing loss are generally lower than their hearing counterparts. Given the cascading effects auditory deprivation and language delays may cause in children, providing differential diagnoses can present a challenge. This course identifies commonly occurring comorbid presentations in children with hearing loss and describes the process of making differential diagnoses.
Presenter(s): A.U. Bankaitis, PhD
Credit(s): PDHs: 1.0, ASHA CEUs*: 0.1
Summary: Medical professionals who use hearing aids can face challenges when they need to perform auscultation (listening to sounds from various organs, most often with a stethoscope) as part of their job. While the options may not seem straightforward, audiologists can play a key role in helping these medical professionals find an amplified stethoscope solution. This on demand webinar will discuss key considerations, potential options, and practical steps for helping medical professionals with hearing loss obtain the best solution.
Presenter(s): Kimberly A Jenkins, PhD, CCC-A
Credit(s): PDHs: 1.0, ASHA CEUs*: 0.1
Summary: In sensitive compartmented information facility (SCIF) environments, hearing aid features such as Bluetooth and bidirectional microphones—which allow seamless communication between hearing aids and communication devices—are considered security risks. This on demand webinar will address considerations for hearing aids for patients who work in secure locations as well as share strategies currently being used by providers within the National Capital Region.
Presenter(s): Sarah Warren, MA
Credit(s): PDHs: 1.0, ASHA CEUs*: 0.1
Summary: Medicare beneficiaries are an important patient population to consider when developing a business model, and SLPs in private practice need to know how to enroll in and bill Medicare to ensure they are compliant with federal law. This course walks through the basics of Medicare credentialing, coding and billing, and documentation to ensure successful processing of claims and medical records that will stand up to scrutiny if audited.
Presenter(s): Meghan Ryan, MSL, Health Policy and Law; Neela Swanson, BA
Credit(s): PDHs: 1.0, ASHA CEUs*: 0.1
Summary: This session discusses the nuances of cash pay and insurance reimbursement, basics of coding for billing, and how to evaluate an insurance denial. Do you have questions about rate setting for cash pay and the differences in insurance reimbursement? Have you struggled with insurance denials and understanding how to resubmit or appeal? While policies are variable across insurance carriers, this session can help you navigate the common processes involved in billing and payment.
Credit(s): PDHs: 1.0, ASHA CEUs*: 0.1
Summary: Ototoxic medications and chemical agents in the workplace can put individuals' hearing and vestibular health at risk for permanent injury. Proactive ototoxicity management (OtoM) strategies aim to minimize exposure, avoid onset of symptoms, provide ongoing monitoring, and manage auditory and vestibular changes as the clinical needs of the patient evolve. During a 2021 American Speech-Language-Hearing Association Special Interest Groups Open House, members of the International Ototoxicity Management Group discussed how best to integrate OtoM into routine clinical practice, what tools to use, and what special considerations need to be understood to best support patients and their families. Here, we have summarized their viewpoints to encourage widespread adoption of improved OtoM services for at-risk individuals. The field of audiology needs to move to a place where we better understand the full extent of ototoxicity and can agree on expanding minimum guidelines that can be implemented more universally to mitigate, detect, and manage the damage from ototoxic exposures. Only recently has our field seen a therapeutic drug that can protect against ototoxicity; however, the population served is restricted only to children receiving treatment for nonmetastatic carcinoma. This is hopefully just the beginning of future therapeutic interventions to come, but, in the meantime, ototoxicity resulting from other medications in different patient populations and chemical agents persists.
<< 1 2 3 4 5 6 7 8 9 10 >>